Xianglin Yuan Selected Research

Xianglin Yuan Research Topics

Disease

73	Neoplasms (Cancer) 04/2024 - 01/2005
20	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2005
17	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 07/2012
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 08/2004
13	Lung Neoplasms (Lung Cancer) 03/2024 - 08/2010
10	Radiation Pneumonitis 01/2020 - 07/2009
9	Stomach Neoplasms (Stomach Cancer) 12/2023 - 07/2016
8	Esophageal Squamous Cell Carcinoma 01/2023 - 01/2015
8	COVID-19 01/2022 - 01/2020
7	Adenocarcinoma of Lung 12/2023 - 01/2005
7	Disease Progression 11/2023 - 06/2010
6	Carcinogenesis 01/2024 - 08/2010
6	Nasopharyngeal Carcinoma 11/2023 - 01/2005
6	Prostatic Neoplasms (Prostate Cancer) 06/2023 - 04/2013
6	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2016
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 04/2017
5	Hypoxia (Hypoxemia) 03/2024 - 01/2005
5	Fibrosis (Cirrhosis) 06/2023 - 10/2018
5	Hypertension (High Blood Pressure) 12/2022 - 08/2009
4	Adenocarcinoma 12/2023 - 01/2019
4	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 04/2015
4	Lung Injury 01/2022 - 10/2016
4	Inflammation (Inflammations) 01/2020 - 03/2016
3	Colonic Neoplasms (Colon Cancer) 11/2023 - 01/2020
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2023 - 01/2022
3	Anemia 10/2022 - 01/2020
3	Neutropenia 04/2022 - 01/2019
3	Diarrhea 01/2022 - 07/2016
3	Nausea 01/2020 - 01/2019
2	Residual Neoplasm 04/2024 - 10/2020
2	Thrombocytopenia (Thrombopenia) 03/2024 - 04/2022
2	Pneumonia (Pneumonitis) 12/2022 - 01/2015
2	Exanthema (Rash) 10/2022 - 01/2020
2	Pathologic Processes 01/2022 - 09/2003
2	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2020
2	Proteinuria 11/2020 - 11/2020
2	Hand-Foot Syndrome 01/2020 - 01/2020
2	Glaucoma 01/2012 - 10/2011

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 03/2024 - 04/2002
20	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2002
9	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
8	RNA (Ribonucleic Acid)IBA 12/2023 - 10/2016
7	ErbB Receptors (EGF Receptor)IBA 01/2023 - 03/2013
6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2005
5	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 01/2005
5	surufatinibIBA 10/2023 - 11/2020
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 08/2010
5	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2016 - 07/2009
4	toripalimabIBA 11/2023 - 01/2021
4	Monoclonal AntibodiesIBA 10/2022 - 08/2016
4	Capecitabine (Xeloda)FDA Link 01/2021 - 01/2020
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 01/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 01/2021
3	MicroRNAs (MicroRNA)IBA 11/2023 - 01/2019
3	Messenger RNA (mRNA)IBA 06/2023 - 01/2020
3	pyrotinibIBA 01/2023 - 12/2020
3	PlatinumIBA 01/2023 - 01/2022
3	CateninsIBA 11/2022 - 01/2020
3	apatinibIBA 04/2022 - 01/2021
3	Polysaccharides (Glycans)IBA 10/2016 - 04/2015
2	Transcription Factors (Transcription Factor)IBA 03/2024 - 01/2014
2	6-methyladenineIBA 12/2023 - 01/2022
2	Gemcitabine FDA Link 11/2023 - 01/2021
2	Competitive Endogenous RNAIBA 11/2023 - 11/2022
2	CollagenIBA 06/2023 - 10/2018
2	Calcium Channels (Calcium Channel)IBA 06/2023 - 01/2022
2	Sorafenib (BAY 43-9006)FDA Link 02/2023 - 12/2022
2	Oxygen (Dioxygen)IBA 02/2023 - 05/2020
2	RamucirumabIBA 12/2022 - 01/2018
2	Cetuximab (Erbitux)FDA Link 05/2022 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2022 - 11/2020
2	IntegrinsIBA 01/2022 - 03/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2020
2	camrelizumabIBA 01/2022 - 01/2021
2	human ERBB2 proteinIBA 03/2021 - 11/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2020
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2020 - 03/2013
2	pirfenidoneIBA 01/2020 - 10/2018
2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 01/2020
2	Cadherins (E-Cadherin)IBA 01/2019 - 04/2015
2	huaierIBA 10/2016 - 04/2015
2	Thymidine PhosphorylaseIBA 07/2016 - 07/2014
2	Matrix Metalloproteinases (MMPs)IBA 07/2015 - 04/2015
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2013 - 01/2013
2	Transforming Growth Factor beta (TGF-beta)IBA 10/2011 - 07/2009
1	oprelvekin (Neumega)FDA Link 03/2024
1	serum P-component (CIt)IBA 03/2024
1	Core Binding Factor alpha SubunitsIBA 03/2024
1	Antineoplastic Agents (Antineoplastics)IBA 03/2024
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2024
1	MucinsIBA 01/2024

Therapy/Procedure

39	Therapeutics 03/2024 - 07/2009
27	Drug Therapy (Chemotherapy) 04/2024 - 08/2004
24	Radiotherapy 06/2023 - 08/2004
11	Immunotherapy 03/2024 - 01/2020
4	Chemoradiotherapy 06/2015 - 08/2010
2	Precision Medicine 12/2023 - 01/2022
1	Platelet Transfusion (Blood Platelet Transfusions) 03/2024